Prominent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice

Blood

Volumn 100, Issue 10, 2002, Pages 3495-3503

  Chagraoui, Hédia ^a,b   Komura, Emiko ^a,b   Tulliez, Micheline ^a,b   Giraudier, Stéphane ^a,b   Vainchenker, William ^a,b   Wendung, Françoise ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Laboratoire d'Anatomopathologie ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; FEMALE; FLOW CYTOMETRY; GENOTYPE; HEMATOPOIESIS; HISTOPATHOLOGY; MALE; MOUSE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0037111643     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-04-1133     Document Type: Article

References (45)

1. Anderson J, Appelbaum F. Myelodysplasia and myeloproliferative disorders. Curr Opin Hematol. 1997;4:261-267.
2. Reilly J. Pathogenesis and management of idiopathic myelofibrosis. Baillieres Clin Haematol. 1998;4:751-767.
3. Barosi G. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol. 1999;17:2954-2970.
4. Jacobson R, Salo A, Fialkow P. Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood. 1978;51:189-194.
5. Greenberg B, Woo L, Veomett I, Payne CM, Ahmann F. Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis. Br J Haematol. 1987;66:487-490.
6. Thiele J, Hoeppner B, Zankovich R, Fischer R, Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/sclerosis (agnogenic myeloid metaplasia): Correlations between clinical and morphological features. Anat Histopathol. 1989;415:191-199.
7. Martyre M. TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leuk Lymphoma. 1995;20:39-44.
8. Martyre M, Le Bousse-Kerdiles MC, Romquin N, et al. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol. 1997;97:441-448.
9. Rameshwar P, Chang V, Thacker U, Gascon P. Systemic transforming growth factor-β in patients with bone marrow fibrosis: Pathophysiological implications. Am J Hematol. 1998;59:133-142.
10. Le Bousse-Kerdiles MC, Martyre M. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol. 1999;78:437-444.
11. Roberts A, Sporn M, Assoian R, et al. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83:4167-4171.
12. Kimura A, Kotoh O, Hyodo H, Kuramoto A. Transforming growth factor-β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br J Haematol. 1989;72:489-491.
13. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol. 1990;6:597-641.
14. Ignotz R, Endo T, Massagné J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem. 1987;262:6443-6446.
15. Mervin J, Anderson J, Kocher O, van Itallie C, Madri J. Transforming growth factor-β modulates extracellular matrix organisation and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol. 1990;142:117-128.
16. Castro-Malaspina H. Pathogenesis of myelofibrosis: Role of ineffective megakaryopoiesis and megakaryocyte components. Prog Clin Biol Res. 1984;154:427-454.
17. Terui T, Niitsu J, Mahara K, et al. The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood. 1990;75:1540-1548.
18. Reilly J, Barnett D, Dolan G, Forrest P, Eastmam J, Smith A. Characterization of an acute micromegakaryocytic leukemia: Evidence for the pathogenesis of myelofibrosis. Br J Haematol. 1993;83:58-62.
19. Ulich TR, Del Castillo J, Senaldi G, et al. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood. 1996;87:5006-5015.
20. Yanagida M, Ide Y, Toriyama M, et al. The role of transforming growth factor-β in PEG-rHuMGDF-induced reversible myelofibrosis in rats. Br J Haematol. 1997;99:739-745.
21. Yan X-Q, Lacey D, Flechter F, et al. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood. 1995;86:4025-4033.
22. Yan X-Q, Lacey D, Hill D, et al. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation. Blood. 1996;88:402-409.
23. Villeval JL, Cohen-Solal K, Tulliez M, et al. High thrombopoietin production by hemopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood. 1997;90:4369-4383.
24. Shull M, Ormsby I, Kier A, et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
25. Kallapur S, Ormsby I, Doetschman T. Strain dependency of TGF-β1 function during embryogenesis. Mol Reprod Dev. 1999;52:341-349.
26. Pear W, Miller J, Xu L, et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 1998;92:3780-3792.
27. Keller J, McNiece I, Sill K, et al. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood. 1990;75:596-602.
28. Sitnicka E, Ruscetti F, Priestley G, Wolf N, Bartelmez S. Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long term repopulating hematopoietic stem cells. Blood. 1996;88:82-88.
29. Ishibashi T, Miller S, Burstein S. Type β transforming growth factor is a potent inhibitor of megakaryocytopoiesis in vitro. Blood. 1987;69:1737-1741.
30. Kuter D, Gminski D, Rosenberg R. Transforming growth factor β inhibits megakaryocytic growth and endomitosis. Blood. 1992;79:619-626.
31. Keller J, Jacobson S, Sill K, Elligsworth L, Ruscetti F. Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte/macrophage-colony stimulating factor. Proc Natl Acad Sci U S A. 1991;88:7190-7194.
32. Border W, Noble N. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
33. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor-β 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770-774.
34. Yan X, Brady G, Iscove N. Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo. Oncogene. 1994;9:163-173.
35. Bonyadi M, Rusholme S, Cousins F, et al. Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice. Nat Genet. 1997;15:207-211.
36. Yaswen L, Kulkarni A, Frederickson T, et al. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood. 1996;87:1439-1445.
37. Burns J, Friedmann T, Driever W, Burrascano M, Yee J. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A. 1993;90:8033-8037.
38. Rebel V, Tanaka M, Lee JS, et al. One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus. Blood. 1999;93:2217-2224.
39. Joyce M, Roberts A, Sporn M, Bolander M. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol. 1990;110:2195-2207.
40. Centrella M, Horowitz M, Wozney J, McCarthy T. Transforming growth factor-β gene family members and bone. Endocr Rev. 1994;15:27-39.
41. Takai H, Kanematsu M, Yano K, et al. Transforming growth factor-β stimulates the production of osteoprotegerin/osteociastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem. 1998;273:27091-27096.
42. Frey B, Rafii S, Teterson M, Eaton D, Crystal R, Moore M. Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: Insights into the pathophysiology of osteomyelofibrosis. J Immunol. 1998;160:691-699.
43. Crawford S, Stellmach V, Murphy-Ullrich J, et al. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell. 1998;93:1159-1170.
44. Munger J, Huang X, Kawakatsu H, et al. The integrin αvβ6 binds and activates latent TGFβ1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319-328.
45. Lee C, Homer R, Zhu Z, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating growth factor β1. J Exp Med. 2001;194:809-821.